Drugs Controller General of India

Bharat Biotech’s Nasal Vaccine iNCOVACC To Cost Rs 800: Sources

The iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein.

December 27, 2022

Global Tender For COVID-19 Vaccines: Odisha Govt Revises Norms To Enable More Vaccine Makers To Participate

Bhubaneswar: Procuring more COVID-19 vaccines is the need of the hour and that can happen only if more and more…

June 1, 2021

COVID-19 Vaccine Update: Clinical Trials For Third Dose Of Covaxin Allowed

New Delhi: An expert panel of Drugs Controller General of India (DCGI) has permitted Bharat Biotech to administer a third…

April 2, 2021

COVID-19 Vaccine: Sputnik V Finally Gets DCGI Nod For Phase 2/3 Trials In India

New Delhi: Having refused permission earlier, the Drugs Controller General of India (DCGI) has now allowed Dr Reddy’s to conduct…

October 17, 2020

All You Need to Know About India’s First Paper-Strip COVID Test Named After Satyajit Ray’s ‘Feluda’

New Delhi: An indigenous paper-strip COVID-19 diagnostic test, named after one of India’s most famous fictitious detectives 'FELUDA', recently received…

September 20, 2020

Panel Recomends Phase II & III Of Human Clinical Trials Of Oxford Vaccine Candidate

New Delhi: There is a recommendation to grant permission to the Serum Institute of India (SII) to conduct the second…

August 1, 2020

Drug Regulator Okays Restrictive Use Of Itolizumab To Treat COVID Patients

New Delhi: India’s drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis, for “restricted emergency use”…

July 11, 2020

COVID Crisis: Remdesivir Hits Drug Regulator Hurdle In India

New Delhi: Even as COVID-19 cases are soaring in India, patients in the country are still to get Remdesivir, an…

June 8, 2020